232 results found in news
news
CareAcross content
CareAcross
Posted about 5 years ago
New Crizotinib side-effect: reduced measures of kidney function during treatment
A University of Colorado Cancer Center study published today in the journal Cancer shows that using crizotinib to treat ALK positive non-small cell lung cancer (NSCLC) appears to reduce kidney function when assessed by one of the most commonly used clinical methods. Whether this reflects a true effect of crizotinib on kidney function, or only on the accuracy of this particular method for assessing it is a topic of ongoing study.
Read full article
CareAcross content
CareAcross
Posted about 5 years ago
Patient-reported outcomes provide valuable insight regarding quality of life for patients with non-small cell lung cancer
An analysis of quality of life (QOL) data of stage III lung cancer patients who received higher doses of radiation therapy (with chemotherapy) shows a significantly lower quality of life at 3 months after treatment compared to patients who received a standard dose of radiation (with chemotherapy), according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting.
Read full article